Inovio pharmaceuticals stock.
The stock option has an exercise price of $0.36, the closing price of INOVIO's common stock on the Grant Date. The stock option will vest and become exercisable with respect to one-fourth of the shares underlying the stock option vested on the Grant Date, and an additional one-fourth of the shares underlying the stock option on the first ...
Shares of Inovio Pharmaceuticals ( INO -2.12%) were down more than 10% on Tuesday afternoon, falling to a 52-week low of $0.07036 a share at one point. The biotechnology company specializes in ...Stock analysis for Inovio Pharmaceuticals Inc (INO:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.Inovio Pharmaceuticals ( INO) reported Q3 2023 earnings per share (EPS) of -$0.13, meeting estimates of -$0.13 by 0.29%. In the same quarter last year, Inovio Pharmaceuticals 's earnings per share (EPS) was -$0.15. Inovio Pharmaceuticals is expected to release next earnings on 02/28/2024, with an earnings per share (EPS) …WebInovio Pharmaceuticals, Inc., et al., No. 2:20-cv-01402-GJP (the “Action”) ... If you purchased or otherwise acquired Inovio common stock between February 14, 2020 and August 10, 2020, inclusive, you are a Class Member.
Stocks INO Overview Inovio Pharmaceuticals Inc. U.S.: Nasdaq About Inovio Pharmaceuticals Inc. See Full Profile Average price target from ratings: $ Full Ratings …Source: Kantar Media. Inovio Pharmaceuticals Inc. historical stock charts and prices, analyst ratings, financials, and today’s real-time INO stock price.
Nov 29, 2023 · 1 Wall Street analysts have issued twelve-month target prices for Inovio Pharmaceuticals' stock. Their INO share price targets range from $2.00 to $2.00. On average, they predict the company's stock price to reach $2.00 in the next year. This suggests a possible upside of 423.3% from the stock's current price. INO stock trades near $10 currently and it is, in fact, down 27% from its pre-Covid high of around $14 in early March 2020 – before the coronavirus pandemic hit the world. INO stock has had a ...Web
INO stock trades near $10 currently and it is, in fact, down 27% from its pre-Covid high of around $14 in early March 2020 – before the coronavirus pandemic hit the world. INO stock has had a ...Webif you purchased or acquired inovio pharmaceuticals, inc.(“inovio”) common stock from february 14, 2020 through august 10, 2020, inclusive (the “class”), you could receive a payment from a ...WebThe stock price of Inovio Pharmaceuticals (NYSE: INO), a biotechnology company focused on synthetic DNA products for treating cancers and infectious diseases, reached its 52-week high levels of ...INO stock trades near $10 currently and it is, in fact, down 27% from its pre-Covid high of around $14 in early March 2020 – before the coronavirus pandemic hit the world. INO stock has had a ...Inovio's stock price has fluctuated widely since the start of 2020, trading at a high of $31.63 per share and a low of $1.38. It opened Friday at $2.51 per share.
Data delayed at least 15 minutes, as of Nov 17 2023 07:01 GMT. More ▽. Find ...
Of the 58 institutional investors that sold Inovio Pharmaceuticals stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: State Street Corp ($36.76M), BlackRock Inc. ($17.40M), Two Sigma Investments LP ($4.16M), Goldman Sachs Group Inc. ($2.35M), Geode Capital Management LLC ...
Galectin Therapeutics Inc. 1.99. -0.13. -6.13%. Get Inovio Pharmaceuticals Inc (INO:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. 3 Jan 2023 ... This could mean hype has come out of the stock because the bottom line is concerning investors. Generally speaking investors would consider ...64.39%. Get the latest Inovio Pharmaceuticals Inc (INO) real-time quote, historical performance, charts, and other financial information to help you make more informed …Inovio Pharmaceuticals: Implied upside of 434%. But the crème de la crème of upside opportunity, at least on this list, is clinical-stage biotech stock Inovio Pharmaceuticals (INO 0.96%).WebThe stock price of Inovio Pharmaceuticals (NYSE: INO), a biotechnology company focused on synthetic DNA products for treating cancers and infectious diseases, reached its 52-week high levels of ...Inovio Pharmaceuticals. Market Cap. $137M. Today's Change. (-3.25%) -$0.02. Current Price. $0.51. You’re reading a free article with opinions that may differ from The Motley Fool’s Premium ...WebA class-action lawsuit claims that pharmaceutical company Inovio deceived the public about developing a COVID-19 vaccine, leading its stock to rise and then crash. Patrick McDermid v. Inovio Pharmaceuticals Inc. et al. Plaintiffs submitted a motion to certify the class action on Thursday, claiming thousands of investors were affected.
From 1998 through today, Inovio Pharmaceuticals' stock history has been largely a depressing one. A quick analysis of Inovio Pharmaceuticals ' ( INO 2.77%) stock performance history shows plenty ...Nov 8, 2022 · As of September 30, 2022, INOVIO had 249.5 million common shares outstanding and 268.7 million common shares outstanding on a fully diluted basis, after giving effect to the exercise, vesting, and conversion, as applicable, of its outstanding options, restricted stock units, convertible preferred stock, and convertible debt. INOVIO reported ... The average trading volume of INO on November 28, 2023 was 3.45M shares. INO) stock’s latest price update. Inovio Pharmaceuticals Inc (NASDAQ: INO)’s stock price has decreased by -3.07 compared to its previous closing price of 0.41. However, the company has seen a -5.38% decrease in its stock price over the last five trading sessions.Data delayed at least 15 minutes, as of Nov 17 2023 07:01 GMT. More ▽. Find ...The stock price of Inovio Pharmaceuticals, a biotechnology company focused on synthetic DNA products for treating cancers and infectious diseases, has seen a large fall of 17% over the last month ...Analysts have been eager to weigh in on the Healthcare sector with new ratings on Actinium Pharmaceuticals (ATNM – Research Report) and Inovio Pharmaceuticals (INO – Research Report).Actinium ...Web
Nov 17, 2021 · It's been a rough 12 months for Inovio Pharmaceuticals (INO-3.67%).In the past year, shares of the company have declined by 35% while the S&P 500 has risen 30%. The main reason for this abysmal ... Dec 1, 2023 · Stock analysis for Inovio Pharmaceuticals Inc (INO:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.
Galectin Therapeutics Inc. 1.99. -0.13. -6.13%. Get Inovio Pharmaceuticals Inc (INO:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.Inovio Pharmaceuticals reported quarterly losses of 15 cents per share which beat the analyst consensus estimate of a loss of 30 cents. The company also reported quarterly sales of $9.15 million ...In a nutshell, Inovio Pharmaceuticals Inc (INO) has experienced a bad performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.As of September 30, 2022, INOVIO had 249.5 million common shares outstanding and 268.7 million common shares outstanding on a fully diluted basis, after giving effect to the exercise, vesting, and conversion, as applicable, of its outstanding options, restricted stock units, convertible preferred stock, and convertible debt. INOVIO reported ...Apr 4, 2023 · Shares of Inovio Pharmaceuticals ( INO -2.12%) were down more than 10% on Tuesday afternoon, falling to a 52-week low of $0.07036 a share at one point. The biotechnology company specializes in ... Stocks trading online may seem like a great way to make money, but if you want to walk away with a profit rather than a big loss, you’ll want to take your time and learn the ins and outs of online investing first. This guide should help get...Nov. 01. MT. Maxim Lowers Price Target for Inovio Pharmaceuticals to $5 From $11, Maintains Buy Rating. 2022. MT. RBC Reinstates Inovio Pharmaceuticals at Sector Perform-Speculative Risk, Assigns $4 Price Target, Awaiting 'More Attractive' Entry Point, 'Clearer Path for Value Creation'.
According to the issued ratings of 1 analysts in the last year, the consensus rating for Inovio Pharmaceuticals stock is Hold based on the current 1 hold rating for INO. The average twelve-month price prediction for Inovio Pharmaceuticals is $2.00 with a high price target of $2.00 and a low price target of $2.00.
Inovio Pharmaceuticals, Inc., et al., No. 2:20-cv-01402-GJP (the “Action”) ... If you purchased or otherwise acquired Inovio common stock between February 14, 2020 and August 10, 2020, inclusive, you are a Class Member.
In addition, Inovio Pharmaceuticals, Inc. has a VGM Score of D ... Inovio Pharma (INO) Stock Surges 19% This Month: Here's Why 10/19/23-8:53AM EST Zacks Inovio Pharmaceuticals ...The Action asserts claims on behalf of all Persons who purchased or otherwise acquired the common stock of Inovio between February 14, 2020 and August 10, 2020, inclusive. Plaintiffs' claims in the Action are set forth in the Second Amended Consolidated Class Action Complaint for Violation of the Federal Securities Laws filed on February 17 ...The stock price of Inovio Pharmaceuticals, a biotechnology company focused on synthetic DNA products for treating cancers and infectious diseases, has seen a large fall of 17% over the last month ...The Action asserts claims on behalf of all Persons who purchased or otherwise acquired the common stock of Inovio between February 14, 2020 and August 10, 2020, inclusive. Plaintiffs' claims in the Action are set forth in the Second Amended Consolidated Class Action Complaint for Violation of the Federal Securities Laws filed on February 17 ...Discover Inovio Pharmaceuticals' earnings and revenue growth rates, forecasts, ... Inovio stock trades higher defying insider sale Jun 07. Consensus forecasts updated Jun 02. Consensus forecasts updated May 18. Forecast breakeven pushed back to …It's been a rough 12 months for Inovio Pharmaceuticals (INO-3.67%).In the past year, shares of the company have declined by 35% while the S&P 500 has risen 30%. The main reason for this abysmal ...INO 1D 2 Month Larger TF shows continuation. Time/Space corrective until wave (B). Breakout of falling wedge finished. Retracement and continuation. Inovio Pharmaceuticals, Inc. engages in the provision of designed DNA medicines to treat and protect people from infectious diseases, cancer, and diseases a 2 Month Larger TF shows continuation. Inovio Pharmaceuticals (INO 2.77%) Q2 2023 Earnings Call Aug 09, 2023, 4:30 p.m. ET. Contents: Prepared Remarks; Questions and Answers; Call Participants; Prepared Remarks: Operator. Good day, and ...Mar 1, 2023 · As of December 31, 2022, INOVIO had 253.1 million common shares outstanding and 271.0 million common shares outstanding on a fully diluted basis, after giving effect to the exercise, vesting, and ... View the latest Inovio Pharmaceuticals Inc. (INO) stock price, news, historical charts, analyst ratings and financial information from WSJ.
Find the latest analyst research for Inovio Pharmaceuticals, Inc. Common Stock (INO) at Nasdaq.com.BLUE BELL, Pa., May 30, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) today announced that its previously announced 1-for-4 reverse stock split shall become effective at 5 P.M ...WebPlymouth Meeting, Pa., June 23, 2023 (GLOBE NEWSWIRE) - INOVIO (NASDAQ:INO) has released the following pursuant to an order of the UNITED STATES DISTRICT COURT EASTERN DISTRICT OF PENNSYLVANIA: UNITED STATES DISTRICT COURT EASTERN DISTRICT OF PENNSYLVANIA IN RE INOVIO PHARMACEUTICALS, INC. DERIVATIVE LITIGATION Lead Case No. 2:20-cv-01962-GJP NOTICE OF PENDENCY AND PROPOSED SETTLEMENT OF ... Instagram:https://instagram. dakota gold corpnasdaq eminilist of health insurance companies in njtriad manufactured home loans Shares of Inovio Pharmaceuticals ... Inovio's stock went on a tear during the first half of the year -- gaining as much as 860% -- mostly thanks to its efforts to develop a vaccine for COVID-19. illumina stockscarvanastock The year-over-year increase in G&A expenses was primarily due to a $14.0 million non-cash expense related to the settlement of INOVIO's securities class action litigation, including the issuance of INOVIO common stock as part of the settlement, $14.3 million in higher legal expenses, primarily related to litigation matters, $6.9 million in one ...Today, let's take a closer look at clinical-stage biotech company Inovio Pharmaceuticals ( INO 4.66%) and see whether it has what it takes to join that select group of millionaire-maker stocks ... 90 day treasury bill rate The stock price of Inovio Pharmaceuticals, a biotechnology company focused on synthetic DNA products for treating cancers and infectious diseases, has seen a large fall of 17% over the last month ...